SALVAGE REGIMENT WITH FLAT FOR REFRACTORY AND RELAPSED AML: EXPERIENCE A SINGLE CENTRE

被引：0
|
作者：
Salamanca, A. [1 ]
Madrigal, D. [1 ]
Saldana, R. [1 ]
Martin, E. [1 ]
Garzon, S. [1 ]
机构：
[1] Hosp Jerez de la Frontera, Area Sanitaria Norte Cadiz, Haematol, Cadiz, Spain
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1667
引用
收藏
页码：681 / 681
页数：1
相关论文
共 50 条
  • [41] FLAG-IDA regimen as salvage chemotherapy before haematopoetic stem cell transplantation in the treatment of refractory/relapsed acute myeloblastic leukaemia: single-centre experience
    Genadieva-Stavrik, S.
    Pivkova, A.
    Stojanoski, Z.
    Karanfilski, O.
    Cevreska, L.
    Georgievski, B.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S418 - S418
  • [42] Efficacy of fludarabine and cytarabine combination for salvage treatment of refractory/relapsed myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML): Promising results from a single center experience.
    Tassara, M
    Ciceri, F
    Crotta, A
    Peccatori, J
    Servida, P
    Bregni, M
    Bernardi, M
    BLOOD, 2005, 106 (11) : 234B - 235B
  • [43] Flag-IDA regimen as salvage chemotherapy before haematopoetic stem cell transplantation in the treatment of refractory/relapsed acute myeloblastic leukaemia: single-centre experience
    Genadieva-Stavrik, S.
    Pivkova, A.
    Stojanoski, Z.
    Sotirova, T.
    Dukovski, D.
    Balkanov, S. Krstevska
    Georgievski, B.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S284 - S284
  • [44] Ifosphamide, etoposide and epirubicin as a salvage treatment and mobilising regimen for patients with refractory and relapsed non-Hodgkin lymphoma and Hodgkin's disease in single-centre experience
    Czyz, A.
    Dytfeld, D.
    Gil, L.
    Nowicki, A.
    Kozlowska, M.
    Parulska, J.
    Sawinski, K.
    Komarnicki, M.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S253 - S253
  • [45] Salvage chemotherapy with alternating MINE-ESHAP regimen for relapsed or refractory Hodgkin's lymphoma previous to autologous stem cell trasplant: a single-centre experience
    de Larrea, C. Fernandez
    Martinez, C.
    Lopez-Guillermo, A.
    Rovira, M.
    Fernandez-Aviles, F.
    Montserrat, E.
    Carreras, E.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S210 - S210
  • [46] Second autologous stem cells transplantation is an effective salvage therapy in relapsed or progressive multiple myeloma: a single centre experience
    Sancetta, R
    Piccin, A
    Pomponi, F
    Raimondi, R
    Miggiano, MC
    Di Bona, E
    Zambello, R
    D'Emilio, A
    Novella, E
    Rodeghiero, F
    BONE MARROW TRANSPLANTATION, 2001, 27 : S249 - S250
  • [47] Combination of bendamustine and rituximab as salvage therapy for patients with relapsed or refractory chronic lymphocytic leukemia: Experience of single center in Russia
    Semochkin, S.
    Ivanova, V. L.
    Lukina, A. I.
    Mukha, L. A.
    Arshanskaya, E. G.
    Lazarev, I. E.
    Kulikova, S. S.
    Pochtar, M. E.
    Huazheva, N. K.
    Markaryan, V. G.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S853 - S853
  • [48] The Use of Clofarabine and Cytarabine Combination (CLARA) As Salvage Therapy for Relapsed and/or Refractory Acute Myeloid Leukemia (AML)
    Leung, Anskar Y. H.
    Tse, Eric
    Liu, Herman S. Y.
    Sim, Joycelyn
    Kho, Bonnie C. S.
    Yip, Sze-Fai
    Lee, Harold K. K.
    Kwong, Yok Lam
    BLOOD, 2012, 120 (21)
  • [49] Comparison of fludarabine-containing salvage chemotherapy regimens for relapsed/refractory acute myelogenous leukemia (AML).
    Thomas, M
    Koller, C
    Yang, Y
    Shen, Y
    O'Brien, S
    Kantarjian, H
    Davis, J
    Estey, E
    BLOOD, 2001, 98 (11) : 224B - 224B
  • [50] FLAG-IDA regimen as bridge therapy to allotransplant in refractory/relapsed aml patients: a single-center experience
    Pasciolla, C.
    Delia, M.
    Pastore, D.
    Carluccio, P.
    Ricco, A.
    Rossi, A. Russo
    Mestice, A.
    Albano, F.
    Specchia, G.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S395 - S395
12345